GeneDx Holdings Corp. (WGS)

GeneDx Holdings Corp.
TickerWGSBörseNasdaq
ISINUS81663L2007CIK0001818331
🔒 Mitglieder
Schluss · 27.07.2026
1T+2,4 %1W−0,2 %1M−13,3 %3M−8,5 %6M−42,3 %1J−24,2 %
GCS 42 → +0,0
TSI 1,0 · 5,2 ▼ 08.07.
8-K 5.02 16.06.26· 43T
Insider ▼ 16.06.26· 43T

Stammdaten

GeneDx Holdings Corp. ist ein patientenzentriertes Health-Intelligence-Unternehmen. Es befasst sich mit der Transformation des Gesundheitswesens durch die Anwendung von KI und maschinellem Lernen auf multidimensionale, längsschnittliche klinische und genomische Daten, um dynamische Modelle der menschlichen Gesundheit zu erstellen und optimale, individualisierte Gesundheitstrajektorien zu definieren. Das Unternehmen generiert durch seine Centrellis-Health-Intelligence-Plattform ein umfassenderes Verständnis von Krankheit und Gesundheit und bietet wissenschaftlich fundierte Lösungen für die dringendsten medizinischen Bedürfnisse. Das Unternehmen wurde von Eric Schadt im Oktober 2015 gegründet und hat seinen Hauptsitz in Stamford, CT. KI

Unternehmen & Branche

NameGeneDx Holdings Corp.
TickerWGS
CIK0001818331
BörseNasdaq
SektorGesundheit
IndustrieGesundheits-IT
SIC8000 · Services-Health Services

Wertpapier & Kennzahlen

CUSIP81663L200
ISINUS81663L2007
TypCommon Stock
Marktkapitalisierung1,73 Mrd. USD
Beta1,95

Sitz & Kontakt

Sitz (Inkorporation)DE
Geschäftsadresse333 LUDLOW STREET NORTH TOWER, 6TH FLOOR, 06902 STAMFORD, CT
Telefon888-729-1206
EIN (IRS)85-1966622

Listing & Historie

Listing-BörsenNasdaq · Nasdaq
Fiskaljahr-Ende31.12.
SEC-Filer-StatusLarge accelerated filer
Frühere NamenSema4 Holdings Corp. (bis 2023)
CM Life Sciences, Inc. (bis 2021)

Bewertung

KBV (P/B)5,61 vs. 40,99 (2021)
KUV (P/S)4,04 vs. 74,96 (2021)
FCF-Rendite0,8 % vs. -1,3 % (2021)

Qualität & Bilanz

Bruttomarge69,7 % vs. -7,8 % (2021)
Operative Marge-3,1 % vs. -210,3 % (2021)
Nettomarge-4,9 % vs. -115,6 % (2021)
ROIC-5,0 % vs. -61,5 % (2021)
Forderungslaufzeit (DSO)63 T vs. 46 T (2021)
Lagerreichweite (DIO)39 T vs. 53 T (2021)
Verbindlichkeitslaufzeit (DPO)7 T vs. 71 T (2021)
Cash-Conversion-Cycle (CCC)96 T vs. 28 T (2021)

Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →

Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
Kennzahl20212022202320242025TTM*Verlauf
Bewertung
KBV (P/B)40,990,400,318,7812,346,80
KUV (P/S)74,960,440,357,058,903,90
FCF-Rendite-1,3 %-318,2 %-259,5 %-1,6 %0,4 %-1,7 %
Qualität & Bilanz
Bruttomarge-7,8 %-11,4 %44,4 %63,6 %69,7 %69,6 %
Operative Marge-210,3 %-284,5 %-89,2 %-7,6 %-3,1 %-14,9 %
Nettomarge-115,6 %-233,9 %-86,8 %-17,1 %-4,9 %-17,6 %
ROIC-61,5 %-165,9 %-50,5 %-14,4 %-5,0 %-22,2 %
Zinsdeckungsgrad-157,4-208,2

Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
TTM* = letzte zwölf Monate (vorläufig, ungeprüft): jüngstes Geschäftsjahr + laufendes YTD − Vorjahres-YTD aus den Quartalsberichten (10-Q); Bewertungs-Multiples gegen die aktuelle Marktkapitalisierung. Kein testierter Jahresabschluss.

Externe Quelle: SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »

Glück Conviction Score™

WGS GeneDx Holdings Corp.
Conviction Score
42
Neutral
Risiko 72
Schwelle niedrighoch
Effektiv Risiko-Ausstieg
Handelsvolumen Mittel
Insider
61,6
2 Insider, 93,0M $ Volumen
Institutionell
32,1
40 neu, 98 erhöht, -1712889K $ netto
Aktivist
0,0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,71% (Stand: 30.06.2026)

Score-Verlauf (90 Tage)

Konviktions-Verlauf — oben stark · Mitte neutral · unten schwach
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.

Kursverlauf (24 Monate)

Indexierte Darstellung (Start = 100) — die Kursform bleibt sichtbar, absolute Kurse sind angemeldeten Mitgliedern vorbehalten.

Technische Indikatoren

52.5
Technical-Score: 52.5 / 100 (informativ, keine Anlageempfehlung)
Bullisch-Anteil 45.5 % — 5 bullisch / 3 bärisch / 3 neutral

Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).

IndikatorSignalGewichtWertDetailBeitrag
Kurs vs SMA50Bullisch10 %58.08+4.2 % vs SMA50
Kurs vs SMA200Bärisch15 %92.20-34.3 % vs SMA200
EMA20 vs EMA50Bullisch5 %62.65EMA50: 61.72
MACD-HistogrammBärisch10 %-0.975Bearisch
RSI(14)Neutral10 %47.2Neutral (30–70)
Stoch %K(14)Bullisch5 %18.5Überverkauft
ADX(14)+DINeutral10 %16.5+DI: 17.9 / −DI: 20.2
Z-Score(60)Neutral5 %0.43In Range
52W-PositionBärisch5 %19.6 %Hoch 167.52 / Tief 34.51
Bollinger(20,2σ)Bullisch5 %18.2 %Upper 71.69 / Mid 64.87 / Lower 58.06
LinReg-Slope(60)Bullisch10 %+0.4192R²=0.51 / annualisiert +188.1 %

Insider-Transaktionen (12 Monate)

DatumInsiderRolleTypStückzahlKursWert (USD)ΔTrend
2026-06-16Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-2.14059,75-127.874,20-10,5%
2026-06-16Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-2.10660,83-128.106,08-10,5%
2026-06-16Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-76059,75-45.413,27-3,7%
2026-06-16Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-86361,50-53.077,52-4,3%
2026-06-16Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-5.93260,83-360.838,22-29,5%
2026-06-16Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-2.42961,50-149.392,00-12,2%
2026-06-09Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-1.26653,77-68.072,82-5,6%
2026-06-09Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-3.63953,77-195.669,03-16,0%
2026-06-05Casdin Capital, LLCDirector, 10% OwnerOpen Market Purchase50.00052,862.642.830,00+216,2%
2026-06-04Casdin Capital, LLCDirector, 10% OwnerOpen Market Purchase150.00056,448.466.735,00+692,6%
2026-06-01Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-36951,74-19.092,06-1,6%
2026-05-20Casdin Capital, LLCDirector, 10% OwnerOpen Market Purchase140.00043,816.132.854,00+501,7%
2026-05-19Casdin Capital, LLCDirector, 10% OwnerOpen Market Purchase185.00042,607.880.334,00+644,7%
2026-05-18Casdin Capital, LLCDirector, 10% OwnerOpen Market Purchase175.00042,557.446.547,50+609,2%
2026-05-15Meister Keith A.Director, 10% OwnerOpen Market Purchase27.40838,281.049.178,24+85,8%
2026-05-15Meister Keith A.Director, 10% OwnerOpen Market Purchase18.86539,83751.392,95+61,5%
2026-05-14Meister Keith A.Director, 10% OwnerOpen Market Purchase88.10739,083.443.221,56+281,7%
2026-05-14Meister Keith A.Director, 10% OwnerOpen Market Purchase51.89339,922.071.568,56+169,5%
2026-05-13Meister Keith A.Director, 10% OwnerOpen Market Purchase94.07438,823.651.952,68+298,8%
2026-05-13Meister Keith A.Director, 10% OwnerOpen Market Purchase70.92639,452.798.030,70+228,9%
2026-05-11Meister Keith A.Director, 10% OwnerOpen Market Purchase246.73438,919.600.419,94+785,4%
2026-05-11Meister Keith A.Director, 10% OwnerOpen Market Purchase252.73439,6510.020.903,10+819,8%
2026-05-11Meister Keith A.Director, 10% OwnerOpen Market Purchase53240,3521.466,20+1,8%
2026-05-08Meister Keith A.Director, 10% OwnerOpen Market Purchase15.74538,00598.310,00+48,9%
2026-05-08Meister Keith A.Director, 10% OwnerOpen Market Purchase79.14440,673.218.786,48+263,3%
2026-05-08Meister Keith A.Director, 10% OwnerOpen Market Purchase73.10441,153.008.229,60+246,1%
2026-05-08Meister Keith A.Director, 10% OwnerOpen Market Purchase3.39638,70131.425,20+10,8%
2026-05-07Meister Keith A.Director, 10% OwnerOpen Market Purchase56.63040,462.291.249,80+187,4%
2026-05-07Meister Keith A.Director, 10% OwnerOpen Market Purchase128.18135,464.545.298,26+371,8%
2026-05-07Meister Keith A.Director, 10% OwnerOpen Market Purchase123.39337,604.639.576,80+379,6%
2026-05-07Meister Keith A.Director, 10% OwnerOpen Market Purchase116.41238,464.477.205,52+366,3%
2026-05-07Meister Keith A.Director, 10% OwnerOpen Market Purchase94.35639,393.716.682,84+304,1%
2026-05-07Meister Keith A.Director, 10% OwnerOpen Market Purchase14.78636,33537.175,38+43,9%
2026-04-29Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-2.15465,20-140.440,80-11,5%
2026-04-29Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-39265,19-25.555,50-2,1%
2026-04-29Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-1864,12-1.154,16-0,1%
2026-03-26Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-9.88365,21-644.512,93-52,7%
2026-03-26Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-13.41263,28-848.699,29-69,4%
2026-03-26Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-13.22961,29-810.817,32-66,3%
2026-03-26Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-5.29264,60-341.859,50-28,0%
2026-03-26Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-5.11762,33-318.952,33-26,1%
2026-03-26Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-2.52063,28-159.463,33-13,0%
2026-03-26Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-2.48561,29-152.307,89-12,5%
2026-03-26Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-1.85765,21-121.102,96-9,9%
2026-03-26Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-99564,60-64.276,30-5,3%
2026-03-26Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-96162,33-59.900,96-4,9%
2026-03-16Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-77277,94-60.166,13-4,9%
2026-03-16Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-3.06577,05-236.156,72-19,3%
2026-03-16Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-2.38476,35-182.016,49-14,9%
2026-03-16Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-25777,94-20.029,40-1,6%
2026-03-16Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-9.22977,05-711.089,84-58,2%
2026-03-16Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-7.17876,35-548.034,56-44,8%
2026-03-09Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-3.67886,75-319.059,14-26,1%
2026-03-09Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-1.28086,75-111.045,12-9,1%
2026-03-05Meister Keith A.Director, 10% OwnerOpen Market Purchase1.97178,91155.531,61+12,7%
2026-03-05Meister Keith A.Director, 10% OwnerOpen Market Purchase60.89281,374.954.782,04+405,3%
2026-03-05Meister Keith A.Director, 10% OwnerOpen Market Purchase47.62380,553.836.032,65+313,8%
2026-03-05Meister Keith A.Director, 10% OwnerOpen Market Purchase29.23682,062.399.106,16+196,3%
2026-03-05Meister Keith A.Director, 10% OwnerOpen Market Purchase30477,9623.699,84+1,9%
2026-03-04Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-1.42477,63-110.539,57-9,0%
2026-03-04Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-10.46578,61-822.621,21-67,3%
2026-03-04Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-9.13379,25-723.782,94-59,2%
2026-03-04Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-5.86177,63-454.966,57-37,2%
2026-03-04Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-2.54378,61-199.897,35-16,4%
2026-03-04Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-2.22079,25-175.933,22-14,4%
2026-03-03Meister Keith A.Director, 10% OwnerOpen Market Purchase19.68670,341.384.713,24+113,3%
2026-03-03Meister Keith A.Director, 10% OwnerOpen Market Purchase8.43971,48603.219,72+49,3%
2026-03-03Meister Keith A.Director, 10% OwnerOpen Market Purchase92175,6669.682,86+5,7%
2026-03-03Meister Keith A.Director, 10% OwnerOpen Market Purchase24975,9918.921,51+1,5%
2026-03-03Meister Keith A.Director, 10% OwnerOpen Market Purchase20072,0014.400,00+1,2%
2026-03-02Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-28777,52-22.247,87-1,8%
2026-02-04Dechairo BryanOfficer, Chief Operating OfficerOpen Market Sale-32888,66-29.081,53-2,4%
2026-02-04Dechairo BryanOfficer, Chief Operating OfficerOpen Market Sale-10090,45-9.045,40-0,7%
2026-02-04Dechairo BryanOfficer, Chief Operating OfficerOpen Market Sale-1.57287,66-137.803,56-11,3%
2026-02-04Dechairo BryanOfficer, Chief Operating OfficerOpen Market Sale-1.42583,83-119.455,90-9,8%
2026-02-04Dechairo BryanOfficer, Chief Operating OfficerOpen Market Sale-1.03484,93-87.815,55-7,2%
2026-02-04Dechairo BryanOfficer, Chief Operating OfficerOpen Market Sale-77983,04-64.684,42-5,3%
2026-02-04Dechairo BryanOfficer, Chief Operating OfficerOpen Market Sale-62386,35-53.795,93-4,4%
2026-02-04Dechairo BryanOfficer, Chief Operating OfficerOpen Market Sale-10091,92-9.192,00-0,8%
2026-02-02Dechairo BryanOfficer, Chief Operating OfficerOpen Market Sale-1.166100,31-116.966,82-9,6%
2026-02-02Dechairo BryanOfficer, Chief Operating OfficerOpen Market Sale-9396,77-8.999,39-0,7%
2026-02-02Dechairo BryanOfficer, Chief Operating OfficerOpen Market Sale-49298,61-48.516,96-4,0%
2026-02-02Dechairo BryanOfficer, Chief Operating OfficerOpen Market Sale-1.66299,40-165.198,48-13,5%
2026-01-29Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-1.65394,00-155.374,89-12,7%
2026-01-29Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-31594,00-29.610,00-2,4%
2026-01-29Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-292,06-184,120,0%
2025-12-16Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-1.628145,36-236.639,89-19,4%
2025-12-16Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-1.031140,08-144.424,95-11,8%
2025-12-16Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-940144,27-135.617,37-11,1%
2025-12-16Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-932148,55-138.448,23-11,3%
2025-12-16Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-604142,12-85.839,69-7,0%
2025-12-16Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-369138,93-51.265,17-4,2%
2025-12-16Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-356140,95-50.178,20-4,1%
2025-12-16Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-274149,20-40.880,25-3,3%
2025-12-16Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-74150,75-11.155,50-0,9%
2025-12-16Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-951141,20-134.285,67-11,0%
2025-12-16Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-699146,93-102.702,81-8,4%
2025-12-16Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-578145,36-84.015,88-6,9%
2025-12-16Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-366140,08-51.270,16-4,2%
2025-12-16Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-334144,27-48.187,45-3,9%
2025-12-16Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-331148,55-49.169,92-4,0%
2025-12-16Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-215142,12-30.555,52-2,5%
2025-12-16Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-131138,93-18.199,83-1,5%
2025-12-16Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-127140,45-17.837,15-1,5%
2025-12-16Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-26150,75-3.919,50-0,3%
2025-12-16Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-97149,20-14.472,21-1,2%
2025-12-16Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-2.679141,20-378.287,39-30,9%
2025-12-16Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-1.970146,93-289.448,55-23,7%
2025-12-09Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-1.266159,28-201.648,48-16,5%
2025-12-09Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-3.639159,28-579.619,92-47,4%
2025-12-01Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-377162,54-61.276,07-5,0%
2025-11-24RUCH JOSHUADirectorOpen Market Sale-8.944160,45-1.435.059,43-117,4%
2025-11-24RUCH JOSHUADirectorOpen Market Sale-11.234161,16-1.810.436,61-148,1%
2025-11-24RUCH JOSHUADirectorOpen Market Sale-6.279159,28-1.000.092,75-81,8%
2025-11-24RUCH JOSHUADirectorOpen Market Sale-2.268161,16-365.503,85-29,9%
2025-11-24RUCH JOSHUADirectorOpen Market Sale-2.016158,40-319.342,26-26,1%
2025-11-24RUCH JOSHUADirectorOpen Market Sale-1.805160,45-289.611,17-23,7%
2025-11-24RUCH JOSHUADirectorOpen Market Sale-1.268159,28-201.961,71-16,5%
2025-11-24RUCH JOSHUADirectorOpen Market Sale-1.117161,16-180.012,26-14,7%
2025-11-24RUCH JOSHUADirectorOpen Market Sale-889160,45-142.639,52-11,7%
2025-11-24RUCH JOSHUADirectorOpen Market Sale-728162,04-117.964,39-9,7%
2025-11-24RUCH JOSHUADirectorOpen Market Sale-625159,28-99.547,38-8,1%
2025-11-24RUCH JOSHUADirectorOpen Market Sale-407158,40-64.470,39-5,3%
2025-11-24RUCH JOSHUADirectorOpen Market Sale-201158,40-31.839,18-2,6%
2025-11-24RUCH JOSHUADirectorOpen Market Sale-147162,04-23.819,73-1,9%
2025-11-24RUCH JOSHUADirectorOpen Market Sale-72162,04-11.666,81-1,0%
2025-10-29Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-4136,75-547,000,0%
2025-10-29Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-388136,54-52.977,52-4,3%
2025-10-29Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-2.154136,54-294.107,16-24,1%
2025-09-30Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-520111,93-58.204,22-4,8%
2025-09-30Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-421110,05-46.329,96-3,8%
2025-09-30Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-387106,86-41.353,81-3,4%
2025-09-30Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-344105,24-36.202,97-3,0%
2025-09-30Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-70113,68-7.957,60-0,7%
2025-09-30Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-5.163108,55-560.457,07-45,8%
2025-09-30Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-4.462107,61-480.159,84-39,3%
2025-09-30Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-1.092106,69-116.506,46-9,5%
2025-09-30Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-645111,84-72.134,09-5,9%
2025-09-30Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-606105,10-63.689,87-5,2%
2025-09-30Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-554109,13-60.457,58-4,9%
2025-09-30Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-136113,68-15.460,48-1,3%
2025-09-30Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-200110,23-22.046,00-1,8%
2025-09-30Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-2.715107,68-292.360,70-23,9%
2025-09-30Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-2.152108,67-233.851,38-19,1%
2025-09-16Stueland KatherineDirector, Officer, CHIEF EXECUTIVE OFFICEROpen Market Sale-10.501121,47-1.275.584,82-104,4%
2025-09-16Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-3.728121,47-452.850,23-37,0%
2025-09-09Stueland KatherineDirector, Officer, Chief Executive OfficerOpen Market Sale-3.639128,05-465.973,95-38,1%
2025-09-09Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-1.266128,05-162.111,30-13,3%
2025-09-09Stueland KatherineDirector, Officer, Chief Executive OfficerOpen Market Sale-18129,08-2.323,42-0,2%
2025-09-09Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-6129,09-774,54-0,1%
2025-09-02Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-378125,81-47.556,03-3,9%
2025-08-27Ryan JasonDirectorOpen Market Sale-3.452128,04-441.996,84-36,2%
2025-08-27Ryan JasonDirectorOpen Market Sale-1.150129,65-149.093,02-12,2%
2025-08-27Ryan JasonDirectorOpen Market Sale-9.890129,59-1.281.689,61-104,9%
2025-08-27Ryan JasonDirectorOpen Market Sale-8.969126,15-1.131.471,64-92,6%
2025-08-27Ryan JasonDirectorOpen Market Sale-8.818125,07-1.102.892,83-90,2%
2025-08-27Ryan JasonDirectorOpen Market Sale-5.443127,44-693.641,22-56,7%
2025-08-27Ryan JasonDirectorOpen Market Sale-1.500130,01-195.015,45-16,0%
2025-08-22Casdin Capital, LLCDirector, 10% OwnerOpen Market Sale-500.000120,90-60.451.950,00-4945,5%
2025-07-29Feeley KevinOfficer, CHIEF FINANCIAL OFFICEROpen Market Sale-388105,31-40.860,28-3,3%
2025-07-29Stueland KatherineDirector, Officer, Chief Executive OfficerOpen Market Sale-2.154105,31-226.837,74-18,6%

Fondsaktivität (Vorquartalsvergleich)

⚠ Vorläufige Daten: Erst 2951 von typischerweise 8401 Fonds (35 %) haben für das aktuelle 13F-Quartal eingereicht — Werte können sich in den kommenden Wochen noch deutlich ändern.

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
Corvex Management LP3.228.14903.228.149207.311.729Neu+100,0%
Casdin Capital, LLC3.007.16403.007.164193.120.072Neu+100,0%
BlackRock, Inc.1.550.70801.550.70899.586.463Neu+100,0%
WESTFIELD CAPITAL MANAGEMENT CO LP1.369.10801.369.10887.924.116Neu+100,0%
GOLDMAN SACHS GROUP INC1.334.98001.334.98085.732.415Neu+100,0%
ARK Investment Management LLC1.324.58301.324.58385.064.722Neu+100,0%
VANGUARD CAPITAL MANAGEMENT LLC858.5830858.58355.138.200Neu+100,0%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC775.2690775.26949.787.775Neu+100,0%
CITADEL ADVISORS LLC768.0010768.00149.321.025Neu+100,0%
Zweig-DiMenna Associates LLC689.7900689.79047.477.204Neu+100,0%
Amova Asset Management Americas, Inc.638.8000638.80041.023.736Neu+100,0%
Sumitomo Mitsui Trust Group, Inc.633.4570633.45740.680.609Neu+100,0%
FRANKLIN RESOURCES INC607.2210607.22138.995.712Neu+100,0%
RAYMOND JAMES FINANCIAL INC610.0730610.07338.768.639Neu+100,0%
GEODE CAPITAL MANAGEMENT, LLC549.1470549.14735.272.985Neu+100,0%
MORGAN STANLEY532.2350532.23534.180.141Neu+100,0%
Prosight Management, LP523.4630523.46333.616.794Neu+100,0%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC479.4180479.41830.788.224Neu+100,0%
STATE STREET CORP472.4450472.44530.340.418Neu+100,0%
EVENTIDE ASSET MANAGEMENT, LLC459.0150459.01529.468.146Neu+100,0%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/358.9780358.97823.053.567Neu+100,0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP348.1050348.10522.355.303Neu+100,0%
WELLINGTON MANAGEMENT GROUP LLP341.0050341.00521.899.341Neu+100,0%
Capital International Investors324.5880324.58820.845.041Neu+100,0%
Assenagon Asset Management S.A.303.43395.128208.30520.830.675Aufgestockt+219,0%
GAGNON SECURITIES LLC303.1490303.14919.468.229Neu+100,0%
FMR LLC295.6210295.62118.984.814Neu+100,0%
DIMENSIONAL FUND ADVISORS LP265.7910265.79117.061.915Neu+100,0%
OBERWEIS ASSET MANAGEMENT INC/261.3700261.37016.785.181Neu+100,0%
Vestal Point Capital, LP250.0000250.00016.055.000Neu+100,0%
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC249.4320249.43216.018.523Neu+100,0%
First Light Asset Management, LLC242.9270242.92715.600.772Neu+100,0%
Science & Technology Partners, L.P.241.2000241.20015.489.864Neu+100,0%
BANK OF AMERICA CORP /DE/234.6060234.60615.066.397Neu+100,0%
Aberdeen Group plc230.0960230.09614.776.765Neu+100,0%
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.221.2450221.24514.208.000Neu+100,0%
RA CAPITAL MANAGEMENT, L.P.209.8870209.88713.478.943Neu+100,0%
FRED ALGER MANAGEMENT, LLC202.7710202.77113.021.954Neu+100,0%
AMERIPRISE FINANCIAL INC195.8890195.88912.580.099Neu+100,0%
Alamea Verwaltungs GmbH185.9890185.98911.944.214Neu+100,0%
Qube Research & Technologies Ltd184.5140184.51411.849.489Neu+100,0%
NORTHERN TRUST CORP175.7670175.76711.287.757Neu+100,0%
ASHFORD CAPITAL MANAGEMENT INC174.5120174.51211.207.161Neu+100,0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC170.6150170.61510.956.895Neu+100,0%
RENAISSANCE TECHNOLOGIES LLC153.7160153.7169.871.642Neu+100,0%
Capital Research Global Investors151.0550151.0559.700.752Neu+100,0%
MILLENNIUM MANAGEMENT LLC364.0120364.0129.628.676Neu+100,0%
Gagnon Advisors, LLC148.2250148.2259.519.009Neu+100,0%
ROYCE & ASSOCIATES LP140.5130140.5139.023.745Neu+100,0%
Engineers Gate Manager LP132.9620132.9628.538.819Neu+100,0%

Top-Fondshalter (Stand: 30.06.2026)

⚠ Vorläufige Daten: Erst 2951 von typischerweise 8401 Fonds (35 %) haben für dieses Quartal eingereicht. Vollständigkeit erwartet bis 14.08.2026. Auswertungen (NEW/INC/DEC) sind noch zu konservativ — viele Spätfiler erscheinen aktuell als „Exits".

FondsAnteileVorquartal (Stk)ΔWert (USD)Anteil (%)StimmkontrolleVerlauf
Assenagon Asset Management S.A.303.43395.128+219,0%20.830.67547,28100 %9 Q
ARDSLEY ADVISORY PARTNERS LP75.000100.000-25,0%5.148.75011,69100 %5 Q
Legal Advantage Investments, Inc.67.04561.675+8,7%4.602.63910,450 %9 Q
Kovack Advisors, Inc.43.09233.960+26,9%2.958.2986,710 %4 Q
Slow Capital, Inc.42.50040.457+5,0%2.917.6256,62100 %5 Q
Y-Intercept (Hong Kong) Ltd27.5210+100,0%1.889.3174,29100 %4 Q
MOODY ALDRICH PARTNERS LLC15.5530+100,0%1.067.7132,4244 %1 Q
Grange Capital, LLC12.2410+100,0%840.3451,910 %1 Q
THOMPSON DAVIS & CO., INC.10.05015.641-35,7%689.9331,570 %13 Q
BENJAMIN EDWARDS INC8.5447.241+18,0%586.4531,33100 %4 Q
NEW YORK STATE COMMON RETIREMENT FUND7.60038.300-80,2%521.7401,18100 %14 Q
B. Riley Wealth Advisors, Inc.7.1080+100,0%491.3051,12100 %1 Q
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC6.8906.772+1,7%452.2601,030 %4 Q
Police & Firemen's Retirement System of New Jersey5.8994.976+18,5%404.9660,92100 %7 Q
HARMONY ASSET MANAGEMENT LLC3.6200+100,0%248.5130,560 %1 Q
Values First Advisors, Inc.770+100,0%236.6790,540 %1 Q
LRI Investments, LLC8370+100,0%57.4600,13100 %1 Q
Versant Capital Management, Inc455476-4,4%31.2360,07100 %14 Q
Cornerstone Planning Group LLC400300+33,3%25.0400,060 %8 Q
SIGNATUREFD, LLC27342+550,0%18.7410,040 %17 Q

Halter-Trend (6 Quartale)

PeriodeStatusHalterAnteile (Mio)Wert (Mio $)
30.06.2026vorl.330,744
31.03.202624935,32.038
31.12.202529436,04.005
30.09.202527234,03.127
30.06.202523434,82.753
31.03.202523034,52.686

Top 10 Neueinsteiger

FondsAnteileWert (USD)
EVENTIDE ASSET MANAGEMENT, LLC459.01529.468.146
Vestal Point Capital, LP250.00016.055.000
First Light Asset Management, LLC242.92715.600.772
Aberdeen Group plc230.09614.776.765
Point72 Asset Management, L.P.75.7954.867.555
KENNEDY CAPITAL MANAGEMENT LLC34.5622.219.572
Kovack Advisors, Inc.33.9602.180.924
LAZARD ASSET MANAGEMENT LLC33.8942.176.673
TUDOR INVESTMENT CORP ET AL33.5402.153.939
DARK FOREST CAPITAL MANAGEMENT LP14.656941.208

Top 10 Aufstocker

FondsAnteileΔ AnteileΔ %Wert (USD)
ARK Investment Management LLC1.324.583720.022+119.1 %85.064.722
Prosight Management, LP523.463468.463+851.8 %33.616.794
CITADEL ADVISORS LLC647.401465.050+255.0 %41.576.093
WESTFIELD CAPITAL MANAGEMENT CO LP1.369.108350.847+34.5 %87.924.116
Amova Asset Management Americas, Inc.638.800257.075+67.3 %41.023.736
Sumitomo Mitsui Trust Group, Inc.633.457251.732+65.9 %40.680.609
Corvex Management LP3.228.149169.520+5.5 %207.311.729
MASSACHUSETTS FINANCIAL SERVICES CO /MA/358.978160.052+80.5 %23.053.567
DIMENSIONAL FUND ADVISORS LP265.791156.603+143.4 %17.061.915
RA CAPITAL MANAGEMENT, L.P.209.887151.843+261.6 %13.478.943

Top 10 Verkäufer

FondsAnteileΔ AnteileΔ %Wert (USD)
FMR LLC295.621-537.117-64.5 %18.984.814
T. Rowe Price Investment Management, Inc.86.082-498.068-85.3 %5.529
FRANKLIN RESOURCES INC607.221-485.767-44.4 %38.995.712
LORD, ABBETT & CO. LLC42.648-475.656-91.8 %2.739
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC479.418-441.169-47.9 %30.788.224
PRICE T ROWE ASSOCIATES INC /MD/266.806-390.965-59.4 %1.481
ALLIANCEBERNSTEIN L.P.20.050-233.404-92.1 %2.607.703
Assenagon Asset Management S.A.95.128-110.767-53.8 %6.109.120
VOYA INVESTMENT MANAGEMENT LLC5.725-74.356-92.9 %367.660
FRED ALGER MANAGEMENT, LLC202.771-63.865-24.0 %13.021.954

Zusätzlich aktuell von 173 Mutual Funds/ETFs gehalten (N-PORT). Alle Fondsgesellschaften & ihre 4-Quartals-Bewegungen →

Aktivisten & Großaktionäre (13D/13G)

DatumInvestorTypAnteilAktienΔΔ-Balken
28.07.2026BlackRock, Inc.Passiv (13G)5,50 %1.622.518Neu
22.05.2026Eli CasdinAktivist (13D/A)13,70 %4.099.671+1,70 pp
22.05.2026Keith A. MeisterAktivist (13D/A)17,90 %5.356.767+5,40 pp
22.05.2026Corvex Management LPAktivist (13D/A)16,10 %4.784.5700,00 pp
22.05.2026CMLS Holdings LLC (+2)Aktivist (13D/A)1,80 %537.285-0,10 pp
22.05.2026Casdin Partners GP, LLCAktivist (13D/A)11,90 %3.526.411+1,70 pp
22.05.2026Casdin Partners Master Fund, L.P. (+1)Aktivist (13D/A)11,80 %3.507.164+1,70 pp
16.05.2026Casdin Partners GP, LLCAktivist (13D/A)10,20 %3.026.4110,00 pp
16.05.2026Corvex Management LPAktivist (13D/A)16,10 %4.784.570+1,20 pp
16.05.2026CMLS HOLDINGS LLC (+2)Aktivist (13D/A)1,80 %537.2850,00 pp
16.05.2026Meister, Keith A.Aktivist (13D/A)17,90 %5.356.767+1,20 pp
16.05.2026Eli CasdinAktivist (13D/A)12,00 %3.599.6710,00 pp
16.05.2026Casdin Partners Master Fund, L.P. (+1)Aktivist (13D/A)10,10 %3.007.1640,00 pp
12.05.2026Eli CasdinAktivist (13D/A)12,00 %3.599.671-0,40 pp
12.05.2026Meister, Keith A.Aktivist (13D/A)16,70 %5.005.494Neu
12.05.2026Corvex Management LPAktivist (13D/A)14,90 %4.433.297+4,30 pp
12.05.2026Casdin Partners Master Fund, L.P. (+1)Aktivist (13D/A)10,10 %3.007.164-0,40 pp
12.05.2026Casdin Partners GP, LLCAktivist (13D/A)10,20 %3.026.411-0,30 pp
12.05.2026CMLS HOLDINGS LLC (+2)Aktivist (13D/A)1,80 %537.285-0,30 pp
12.11.2025WILLIAM BLAIR INVESTMENT MANAGEMENT, LLCPassiv (13G/A)4,30 %1.235.681-1,40 pp
26.08.2025CMLS Holdings LLC (+2)Aktivist (13D/A)1,90 %537.2850,00 pp
26.08.2025Corvex Management LPAktivist (13D/A)10,60 %3.058.629+0,40 pp
26.08.2025Casdin Partners GP, LLCAktivist (13D/A)10,50 %3.026.411-1,90 pp
26.08.2025Casdin Partners Master Fund, L.P. (+1)Aktivist (13D/A)10,50 %3.007.164-0,80 pp
26.08.2025Keith A. MeisterAktivist (13D/A)12,50 %3.630.826+0,40 pp
26.08.2025Eli CasdinAktivist (13D/A)12,40 %3.599.671-2,50 pp
14.08.2025Summit Partners Sustainable Opportunities L/S Fund LimitedPassiv (13G/A)0,83 %235.761-0,15 pp
14.08.2025Summit Partners Concentrated Growth L/S Master Fund, L.P.Passiv (13G/A)0,36 %103.992-0,91 pp
14.08.2025Summit Partners, L.P.Passiv (13G/A)2,70 %771.333-1,43 pp
14.08.2025Summit Partners Sustainable Opportunities L/S Fund, L.P.Passiv (13G/A)0,04 %10.272+0,01 pp
14.08.2025Summit Partners Sustainable Opportunities L/S QP Fund, L.P.Passiv (13G/A)1,24 %353.762+0,07 pp
14.08.2025Summit Partners Alydar GP, L.P. (+1)Passiv (13G/A)1,88 %535.572-1,28 pp
14.08.2025Summit Partners Public Asset Management, LLC (+4)Passiv (13G/A)3,04 %867.265-2,15 pp
14.08.2025Summit Partners Technology L/S Master Fund, L.P.Passiv (13G/A)0,24 %67.546-0,44 pp
06.08.2025Abigail P. Johnson (+1)Passiv (13G/A)0,60 %163.324-9,40 pp
30.07.2025WILLIAM BLAIR INVESTMENT MANAGEMENT, LLCPassiv (13G)5,70 %1.631.402Neu
12.05.2025Abigail P. Johnson (+1)Passiv (13G)10,00 %2.793.953Neu
09.05.2025THE GOLDMAN SACHS GROUP, INC. (+1)Passiv (13G/A)3,90 %1.106.752-1,30 pp
07.05.2025CMLS Holdings LLC (+2)Aktivist (13D/A)1,90 %537.285Neu
07.05.2025CASDIN PARTNERS MASTER FUND, L.P. (+1)Aktivist (13D/A)12,30 %3.507.164+2,00 pp

Finanzkennzahlen (SEC XBRL)

Währung:
PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2026-03-3110-Q102.254.000 $-63.316.000 $-2,16 $506.301.000 $254.124.000 $
2025-12-3110-K427.539.000 $-21.021.000 $-0,73 $523.710.000 $308.182.000 $
2025-09-3010-Q116.743.000 $-7.635.000 $-0,27 $493.902.000 $292.258.000 $
2025-06-3010-Q102.692.000 $10.809.000 $0,36 $463.863.000 $277.133.000 $
2025-03-3110-Q87.115.000 $-6.529.000 $-0,23 $446.430.000 $257.405.000 $
2024-12-3110-K305.450.000 $-52.286.000 $-1,94 $419.380.000 $245.247.000 $
2024-09-3010-Q76.874.000 $-8.312.000 $-0,31 $408.840.000 $204.501.000 $
2024-06-3010-Q70.514.000 $-29.173.000 $-1,10 $389.100.000 $194.043.000 $
2024-03-3110-Q62.422.000 $-20.239.000 $-0,78 $394.528.000 $207.217.000 $
2023-12-3110-K202.566.000 $-175.767.000 $-7,23 $418.756.000 $228.017.000 $
2023-09-3010-Q53.303.000 $-42.286.000 $-1,64 $417.285.000 $254.258.000 $
2023-06-3010-Q48.706.000 $-46.719.000 $-1,84 $476.390.000 $296.113.000 $
2023-03-3110-Q43.139.000 $-60.989.000 $-3,04 $545.295.000 $328.469.000 $
2022-12-3110-K234.694.000 $-548.980.000 $-53,63 $490.942.000 $253.705.000 $
2022-09-3010-Q83.234.000 $-77.581.000 $-6,72 $828.974.000 $561.294.000 $
2022-06-3010-Q36.169.000 $-85.742.000 $-8,38 $933.280.000 $637.274.000 $
2022-03-3110-Q53.941.000 $-76.896.000 $-10,38 $517.670.000 $329.444.000 $
2021-12-3110-K212.195.000 $-245.390.000 $-2,27 $554.093.000 $388.103.000 $
2021-09-3010-Q43.178.000 $32.731.000 $0,16 $603.357.000 $391.021.000 $
2021-06-3010-Q47.015.000 $-46.161.000 $-41,94 $443.182.377 $-566.504.000 $

Umsatz nach Segmenten & Regionen

Geschäftssegmente

SegmentFY 2025FY 2024FY 2023FY 2022FY 2021AnteilΔTrend
Diagnostic Test416,7 Mio.302,2 Mio.195,7 Mio.227,3 Mio.205,1 Mio.97,5 %+37,9%
Diagnostic Test Third Party Insurance345,2 Mio.234,7 Mio.134,5 Mio.173,6 Mio.169,6 Mio.80,7 %+47,1%
Diagnostic Test Institutional Customers70,1 Mio.65,1 Mio.59,5 Mio.46,1 Mio.31,7 Mio.16,4 %+7,6%
Product And Service Other10,9 Mio.3,3 Mio.6,9 Mio.7,4 Mio.7,1 Mio.2,5 %+230,1%
Diagnostic Test Self Pay1,4 Mio.2,3 Mio.1,7 Mio.7,6 Mio.3,8 Mio.0,3 %-41,9%

Quartalsverlauf

SegmentQ3 FY2025Q2 FY2025Q1 FY2025Q3 FY2024Q2 FY2024Q1 FY2024AnteilΔTrend
Diagnostic Test113,5 Mio.99,8 Mio.85,8 Mio.77,4 Mio.69,4 Mio.61,1 Mio.97,2 %+46,6%
Diagnostic Test Third Party Insurance95,0 Mio.81,1 Mio.68,1 Mio.59,5 Mio.52,1 Mio.43,8 Mio.81,4 %+59,6%
Diagnostic Test Institutional Customers17,9 Mio.18,4 Mio.17,6 Mio.17,4 Mio.16,7 Mio.16,7 Mio.15,3 %+2,6%
Product And Service Other3,2 Mio.2,9 Mio.1,4 Mio.-544.0001,1 Mio.1,3 Mio.2,8 %+691,9%
Diagnostic Test Self Pay629.000339.00096.000460.000692.000591.0000,5 %+36,7%

Quartalsergebnisse (Earnings)

QuartalStichtagVerkündetUmsatzEPS
Q1 202631.03.202604.05.2026102,3 Mio. USD-2,16
Q3 202530.09.202528.10.2025116,7 Mio. USD-0,27
Q2 202530.06.202529.07.2025102,7 Mio. USD0,36
Q1 202531.03.202530.04.202587,1 Mio. USD-0,23
Q3 202430.09.202429.10.202476,9 Mio. USD-0,31
Q2 202430.06.202430.07.202470,5 Mio. USD-1,10
Q1 202431.03.202429.04.202462,4 Mio. USD-0,78
Q3 202330.09.202303.11.202353,3 Mio. USD-1,64
Q2 202330.06.202308.08.202348,7 Mio. USD-1,84

Einreichungs-Historie (10-K / 10-Q / 20-F / 6-K)

SEC-Einreichungs-Historie der letzten sechs Jahre (Datum = US-Kalendertag, SEC/ET): Quartalsberichte (10-Q) und Jahresberichte (10-K); ausländische Emittenten (ADR/Foreign Private Issuer) reichen stattdessen Jahresberichte (20-F/40-F) und Zwischenmitteilungen (6-K) ein — dort liegt im SEC-Index keine Berichtsperiode vor, Periode und Verzögerung bleiben leer. Die Spalte „Verzögerung" zeigt die Tage zwischen Berichtsstichtag und tatsächlicher Einreichung. Suffix /A kennzeichnet nachträgliche Berichtigungen.

Eingereicht (US)FormBerichtsperiodeVerzögerung
04.05.202610-Q31.03.202634 TageSEC »
23.02.202610-K31.12.202554 TageSEC »
28.10.202510-Q30.09.202528 TageSEC »
29.07.202510-Q30.06.202529 TageSEC »
30.04.202510-Q31.03.202530 TageSEC »
20.02.202510-K31.12.202451 TageSEC »
29.10.202410-Q30.09.202429 TageSEC »
30.07.202410-Q30.06.202430 TageSEC »
29.04.202410-Q31.03.202429 TageSEC »
23.02.202410-K31.12.202354 TageSEC »
03.11.202310-Q30.09.202334 TageSEC »
08.08.202310-Q30.06.202339 TageSEC »
09.05.202310-Q31.03.202339 TageSEC »
16.03.202310-K31.12.202275 TageSEC »
14.11.202210-Q30.09.202245 TageSEC »
15.08.202210-Q30.06.202246 TageSEC »
12.05.202210-Q31.03.202242 TageSEC »
14.03.202210-K31.12.202173 TageSEC »
15.11.202110-Q30.09.202146 TageSEC »
21.07.202110-Q30.06.202121 TageSEC »
24.05.202110-Q31.03.202154 TageSEC »
05.05.202110-K/A31.12.2020125 TageSEC »
30.03.202110-K31.12.202089 TageSEC »
16.11.202010-Q30.09.202047 TageSEC »

Kapitalerhöhungen & Emissions-Historie

Emissions-Historie aus den finalen SEC-Prospekten: Börsengang (424B4) und Kapitalerhöhungen (424B5, Folge-/Sekundärplatzierungen). Volumen = Brutto-Erlös (bei Börsengängen zusätzlich der Ausgabepreis). Wiederholte Kapitalerhöhungen deuten auf Verwässerung der Altaktionäre hin.

Datum (US)ArtVolumen
30.04.2024Kapitalerhöhung$75,0 MioSEC »
29.04.2024Kapitalerhöhung$75,0 MioSEC »
30.01.2023Kapitalerhöhung$115,0 Mio · $0,35/AktieSEC »
30.01.2023Kapitalerhöhung$35,0 Mio · $0,35/AktieSEC »
26.01.2023KapitalerhöhungSEC »

Datum = US-Einreichungsdatum (SEC EDGAR, ET). Beträge in US-Dollar.

Proxy-/Governance-Filings

Proxy-Statements (SEC DEF-14A-Familie) der letzten sechs Jahre: reguläre HV-Einladungen zur Aktionärsversammlung, Aktivisten-Proxy-Fights (contested / Non-Management-Solicitation) und M&A-Abstimmungen.

Datum (US)KategorieHV-Termin (US)Stichtag (US)Form
30.04.2026HV-EinladungDEFA14ASEC »
30.04.2026HV-Einladung18.06.2026 Jahres-HV20.04.2026DEF 14ASEC »
30.04.2025HV-EinladungDEFA14ASEC »
30.04.2025HV-Einladung18.06.2025 Jahres-HV21.04.2025DEF 14ASEC »
29.04.2024HV-EinladungDEFA14ASEC »
29.04.2024HV-Einladung20.06.2024 Jahres-HV24.04.2024DEF 14ASEC »
06.06.2023HV-EinladungDEFA14ASEC »
28.04.2023HV-Einladung14.06.2023 Jahres-HV08.05.2023DEF 14ASEC »
31.03.2023HV-Einladung14.04.2023 a.o. HV24.03.2023DEF 14ASEC »
21.03.2023VorläufigPRE 14ASEC »
18.04.2022HV-EinladungDEFA14ASEC »
31.03.2022M&A-Abstimmung27.04.2022 a.o. HV22.03.2022DEFM14ASEC »
15.03.2022HV-EinladungDEFA14ASEC »
15.03.2022M&A-AbstimmungPREM14ASEC »
14.03.2022HV-EinladungDEFA14ASEC »
08.03.2022HV-EinladungDEFA14ASEC »
22.02.2022HV-EinladungDEFA14ASEC »
17.02.2022HV-EinladungDEFA14ASEC »
18.01.2022HV-EinladungDEFA14ASEC »
18.01.2022HV-EinladungDEFA14ASEC »
19.07.2021HV-EinladungDEFA14ASEC »
02.07.2021M&A-Abstimmung21.07.2021 a.o. HVDEFM14ASEC »
28.06.2021VorläufigPRER14ASEC »
11.06.2021HV-EinladungDEFA14ASEC »
11.06.2021HV-EinladungDEFA14ASEC »
10.06.2021VorläufigPRER14ASEC »
06.05.2021M&A-AbstimmungPREM14ASEC »
12.02.2021HV-EinladungDEFA14ASEC »
11.02.2021HV-EinladungDEFA14ASEC »
10.02.2021HV-EinladungDEFA14ASEC »

Datum = US-Einreichungsdatum (SEC EDGAR, ET). HV-Termin = Datum der Aktionärsversammlung, Stichtag (Record Date) = Nachweisstichtag für die Stimmberechtigung (aus dem Dokument extrahiert).

Übernahmen & Fusionen (M&A)

M&A-relevante SEC-Filings der letzten sechs Jahre: Übernahmeangebote (Tender Offers), Fusionen (425/S-4), Aktienrückkauf-Angebote (Self-Tender) und Going-Private-Transaktionen. Geführt nach dem einreichenden Emittenten.

Datum (US)KategorieFormDeal-KonditionenSEC
07.05.2021Fusion425Ziel: Sema4SEC »
05.05.2021Fusion425Ziel: CM Life Sciences, Inc.SEC »

Datum = US-Einreichungsdatum (SEC EDGAR, ET). Deal-Konditionen aus dem Dokument extrahiert (Tender: SC TO-T/-I/SC 14D9; Fusion: 425/S-4 — Gegenpartei + Umtauschverhältnis), ohne Gewähr — Original siehe SEC-Link.

Kritische 8-K Meldungen

WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (16.06.2026)
DatumMeldungTagsSchwereFilingAuszug
16.06.2026Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
18.09.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
02.01.2025Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
24.07.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
28.04.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers…
17.04.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
14.04.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
14.02.2023Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
26.08.2022Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
01.07.2022Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
14.06.2022Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
02.05.2022Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
14.03.2022Item 4.02 — BilanzkorrekturenEXTREMSECItem 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review…
14.03.2022Item 4.02 — BilanzkorrekturenEXTREMSECItem 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review…
31.01.2022Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
18.01.2022Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
14.10.2021Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
28.07.2021Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers…
05.05.2021Item 4.02 — BilanzkorrekturenEXTREMSECItem 4.02 with the Independent Accountants. Important Information About the Business Combination and Where to Find It…
04.09.2020Item 5.02 — Abgang SchlüsselpersonenHOCHSECItem 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;…

8-K-Ereignisse (KI)

🔒 Die vollständige KI-Einordnung je 8-K ist Teil des Kunden-Abos — freischalten.

DatumEreignisSentimentMaterialitätZusammenfassungFiling
23.06.2026HV-Abstimmung0,0028GeneDx Holdings führte am 18. Juni 2026 die Jahreshauptversammlung durch, auf der Aktionäre über mehrere Anträge abstimmten. Die Details sin… 🔒SEC
16.06.2026Personalwechsel0,2545Mark Gardner (60) wurde zum Präsidenten ernannt und übernimmt ab 15. Juni 2026 Leitung von Labor- und Geschäftsbetrieb. Er berichtet an CEO … 🔒SEC
04.05.2026Quartalszahlen0,0025GeneDx Holdings Corp. kündigt Finanzergebnisse für Q1 2026 an und wird eine Konferenzschaltung abhält. Weitere Details sind nicht im Excerpt… 🔒SEC
02.03.2026Finanzierung/Anleihe0,1570GeneDx schloss am 27.02.2026 einen Darlehensvertrag mit Blackstone Alternative Credit Advisors LP und Blackstone Life Sciences Advisors LLC … 🔒SEC
23.02.2026Quartalszahlen0,0065GeneDx Holdings gibt Jahresergebnisse für 2025 per Pressemitteilung und Telefonkonferenz bekannt. Detaillierte Ergebnisse und Präsentation w… 🔒SEC
12.01.2026Guidance-Update0,0570GeneDx kündigte vorläufige Umsätze, Test-Volumina und Margenerwartungen für Q4 2025 und das Gesamtjahr 2025 an.SEC

Fail-to-Deliver (6 Monate)

DatumFTD-MengeKursWert (USD)
2026-06-1726660,6016.120
2026-05-2669447,3132.833
2026-05-1412838,944.984
2026-05-13139,4939
2026-05-12839,61317
2026-05-1180040,7732.616
2026-05-0810040,504.050
2026-05-0621.18834,51731.198
2026-05-0522.15567,931.504.989
2026-04-231.93369,83134.981
2026-04-207265,964.749
2026-04-1030060,0518.015
2026-04-0610066,206.620
2026-03-20173,0073
2026-03-173676,112.740
2026-03-131.45176,85111.509
2026-03-102394,512.174
2026-03-093.62188,11319.046
2026-03-063.55782,00291.674
2026-03-052.65179,47210.675
2026-02-2322682,0618.546
2026-02-1942492,0439.025
2026-02-0933684,2928.321
2026-02-04195,2395
2026-02-032399,012.277

Hinweis

Erweitert ×